Hyperbilirubinemia with mild COVID-19 patient: A case report.
Int J Surg Case Rep
; 82: 105958, 2021 May.
Article
in English
| MEDLINE | ID: covidwho-1220871
ABSTRACT
INTRODUCTION AND IMPORTANCE Increased total serum bilirubin rarely reported in mild COVID-19 patients. It occurs mostly in severe cases, particularly in those who have liver diseases and admitted to an intensive care unit. The main cause of increased liver biochemistries in Covid-19 patients related to used drugs, the presence of the ACE2 receptor in the liver, and robust inflammatory response. However, limited studies available regarding to jaundice in COVID19 patients. CASE PRESENTATION Here we present a case of hyperbilirubinemia in a mild asymptomatic COVID-19 patient, the patient was diagnosed by RT-PCR three days prior to presentation fever, dark urine, and of acute onset of jaundice. The patient was diagnosed by physical examination and laboratory findings, and treated successfully by high-quality natural honey. CLINICAL DISCUSSION:
A recent studies of COVID-19 increased total serum bilirubin have been reported, mostly after the appearance of the COVID-19 symptoms. The case in the current study was a 48-year-old male patient who was diagnosed with mild COVID-19 three days prior to presentation. After 2 days increased total serum bilirubin.CONCLUSION:
Honey is a natural medicine to treat Jaundice in mild COVID-19 patients. However, significant data on larger studies are still lacking to decide. Our case guides for the clinical treatment of conjunctival icterus in mild COVID-19 patients.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
/
Qualitative research
Language:
English
Journal:
Int J Surg Case Rep
Year:
2021
Document Type:
Article
Affiliation country:
J.ijscr.2021.105958
Similar
MEDLINE
...
LILACS
LIS